Potential new antitumor agents from an innovative combination of camphorato, a ramification of traditional Chinese medicine, with a platinum moiety

Eight new camphorato platinum complexes have been synthesized and evaluated for their in vitro cytotoxicity against HL-60 human leukemia, 3AO human ovarian carcinoma, BEL-7402 human hepatocarcinoma, and A549 human lung carcinoma cell lines. Most complexes showed good cytotoxic activity against the above-selected cell lines. Among the complexes, two compounds were assayed for their in vivo antitumor activity against LS-174T human colon carcinoma cells implanted in mice. One complex exhibited not only higher in vivo antitumor activity, but also less toxicity than oxaliplatin when it was administered intravenously at a dose of 6 mg/kg three times.

Eight new camphorato platinum complexes have been synthesized and evaluated for their in vitro cytotoxicity against four human tumor cell lines. The antitumor activities of compounds 3a and b were assayed in vivo against LS-174T human colon carcinoma cell line. Complex 3b exhibited not only higher in vivo antitumor activity, but also less toxicity than oxaliplatin when it was administered intravenously three times at a dose of 6 mg/kg.Figure optionsDownload as PowerPoint slide